YURAK QON TOMIR FIZIOLOGIYASI VA UNDAGI MUAMMOLAR
Keywords:
Gipertoniya, endokard, miokard epikard, chap va o'ng atriya, chap va o'ng qorinchalar.Abstract
Yurak va qon tomir tizimi, tana a'zolarining normal ishlashini ta'minlash uchun muhim fiziologik tizimlardan biridir. Yurak qon tomir tizimi, organizmda oziq moddalarini, kislorodni va chiqindilarni tashishning asosi hisoblanadi. Bu tizimning sog‘lom ishlashi, butun tana a'zolarining faoliyatini to‘g‘ri amalga oshirishini ta'minlaydi. Ushbu maqolada yurak qon tomir tizimining asosiy xususiyatlari, uning tarkibiy qismlari, qon aylanishining mexanizmlari va fiziologik ahamiyati tahlil qilinadi.
References
1. Guyton, A. C., & Hall, J. E. (2011). Textbook of Medical Physiology. Elsevier Saunders.
2. Costanzo, L. S. (2017). Physiology. Elsevier.
3. Boron, W. F., & Boulpaep, E. L. (2009). Medical Physiology. Elsevier.
4. Lee, Y.; Ahn, C.; Han, J.; Choi, H.; Kim, J.; Yim J.; Lee, J.; Provost, P.; Rådmark, O.; Kim, S.; Kim, V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003, 425, 415–419.
5. Gregory, R.I.; Yan, K.; Amuthan, G.; Chendrimada, T.; Doratotaj, B.; Cooch, N.; Shiekhattar, R.. The microprocessor complex mediates the genesis of microRNAs. Nature, 2004, 432, 235–240.
6. Thum, T.; Catalucci, D.; Bauersachs, J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc. Res., 2008, 79, 562-70.
7. Pan, Z.W.; Lu, Y.J.; Yang, B.F. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases. Acta Pharmacol. Sin. 2010, 31, 1-9.
8. Sh.M.Gulyamov, N.J.Khojieva, S.Isakova. Oxergy Analysis of the Installation of Primary Oil Refining // ISSN 1815-4840 Сhemical technology. Control and management 2020, №5-6 (95-96) pp.116-122.
9. Tousoulis, D.; Kampoli, A.M.; Stefanadi, E.; Antoniades, C.; Siasos, G.; Papavassiliou, A.G.; Stefanadis, C. New biochemical markers in acute coronary syndromes. Curr. Med. Chem. 2008, 15, 1288-96
10. Condorelli, G.; Latronico, M.V.; Dorn, G.W. 2nd. microRNAs in heart disease: putative novel therapeutic targets? Eur. Heart J., 2010, 31, 649-58.
11. Dong, D.L.; Chen, C.; Huo, R.; Wang, N.; Li, Z.; Tu, Y.J.; Hu, J.T.; Chu, X.; Huang, W.; Yang, B.F. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension, 2010, 55, 946-52.
12. Haver, V.G.; Slart, R.H.; Zeebregts, C.J.; Peppelenbosch, M.P.; Tio, R.A. Rupture of vulnerable atherosclerotic plaques: MicroRNAs conducting the orchestra? Trends Cardiovasc. Med., 2010, 20, 65-71.
